|
| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Septicemia
|
NHLBI
|
1K23HL084191-01A1
|
|
CD80 and CD86 mediated innate immune response in sepsis
|
NOLAN, ANNA
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$159,138
|
|
Septicemia
|
NHLBI
|
5K08HL081229-03
|
|
Role of IRAK-M in sepsis-induced immunosuppression
|
DENG, JANE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$121,770
|
|
Septicemia
|
NIGMS
|
5R01GM059694-08
|
|
Bacterial Membrane Proteins in Gram-Negative Sepsis
|
WARREN, H
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$352,493
|
|
Septicemia
|
NIGMS
|
5R01GM053209-14
|
|
Programmed Cell Death: Role in Septic Immune Dysfunction
|
AYALA, ALFRED
|
RHODE ISLAND HOSPITAL (PROVIDENCE, RI)
|
RI
|
$259,170
|
|
Septicemia
|
NIAID
|
5R01AI064789-03
|
|
Nitric oxide and mitochondrial biogenesis in sepsis
|
PIANTADOSI, CLAUDE
|
DUKE UNIVERSITY
|
NC
|
$260,046
|
|
Septicemia
|
NIAID
|
5R01AI062921-04
|
|
Role of Macrophage Arginase in Anti-Bacterial Immunity
|
MURRAY, PETER
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$244,169
|
|
Septicemia
|
NIGMS
|
5R01GM050441-14
|
|
Post-Traumatic Sepsis: Regulation of LPS Binding Protein
|
BILLIAR, TIMOTHY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$264,958
|
|
Septicemia
|
NIAID
|
5U01AI061246-04
|
|
DNA Minor Groove-binding Drugs and Food-borne Pathogens
|
PERRELLA, MARK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$408,264
|
|
Septicemia
|
NIGMS
|
5R01GM053008-14
|
|
Modulation of Hepatocellular Function in Sepsis
|
WANG, PING
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$311,458
|
|
Septicemia
|
NIAID
|
7R01AI058107-04
|
|
PRIMATE MODEL AND PATHOGENESIS OF ANTHRAX SEPSIS
|
KUROSAWA, SHINICHIRO
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$487,215
|
|
Septicemia
|
NIDDK
|
5R01DK038201-20
|
|
Regulation of sinusoidal perfusion in shock
|
CLEMENS, MARK
|
UNIVERSITY OF NORTH CAROLINA CHARLOTTE
|
NC
|
$215,604
|
|
Septicemia
|
NHLBI
|
5R01HL076278-04
|
|
Macrophage Inflammasome Regulation
|
WEWERS, MARK
|
OHIO STATE UNIVERSITY
|
OH
|
$354,382
|
|
Septicemia
|
NIAID
|
5R01AI044005-10
|
|
Antigenic variation in rickettsial transmission
|
PALMER, GUY
|
WASHINGTON STATE UNIVERSITY
|
WA
|
$273,096
|
|
Septicemia
|
NIAID
|
5R01AI042015-10
|
|
Regulation of the (poly) sialic virulence factor
|
VIMR, ERIC
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$177,895
|
|
Septicemia
|
NIAID
|
5R01AI065791-03
|
|
NF-kB and Chromatin Changes in Human Sepsis
|
MCCALL, CHARLES
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$307,555
|
|
Septicemia
|
NIAID
|
5R01AI061031-04
|
|
Control of virulence in Neisseria meningitidis
|
TZENG, YIH-LING
|
EMORY UNIVERSITY
|
GA
|
$284,630
|
|
Septicemia
|
NIAID
|
5R01AI045896-09
|
|
LPS Efflux from Host Cells to Plasma Lipoproteins
|
KITCHENS, RICHARD
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$290,211
|
|
Septicemia
|
NIGMS
|
5R21GM079255-02
|
|
Induction of Autophagy in Human Macrophages by Lipopolysaccharide
|
HAIMOVICH, BEATRICE
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
NJ
|
$235,831
|
|
Septicemia
|
NIAID
|
5R01AI067522-02
|
|
Role of Macrophage Costimualtory Molecules in Polymicrobial Sepsis
|
GOLD, JEFFREY
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$377,685
|
|
Septicemia
|
NIGMS
|
5R01GM057463-09
|
|
Lipoproteins Modulate the Hepatic Response to Endotoxin
|
HARRIS, HOBART
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$305,255
|
|
Septicemia
|
NIAID
|
5R01AI059524-04
|
|
Effect of Bacterial Tolerance on TLR4 Signal Transduction
|
MEDVEDEV, ANDREI
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$310,793
|
|
Septicemia
|
NIAID
|
5R01AI045459-08
|
|
Variable Gene Use and Pneumococcal Immunity in AIDS
|
PIROFSKI, LIISE-ANNE
|
YESHIVA UNIVERSITY
|
NY
|
$395,309
|
|
Septicemia
|
NIAID
|
5R01AI054928-05
|
|
Candida Invasion of Endothelium and Virulence
|
FILLER, SCOTT
|
LA BIOMED RES INST/ HARBOR UCLA MED CTR
|
CA
|
$274,647
|
|
Septicemia
|
NIGMS
|
5R01GM058531-10
|
|
Thrombin,Sepsis and Mechanisms of Inflammation
|
TIRUPPATHI, CHINNASWAMY
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$283,650
|
|
Septicemia
|
NHLBI
|
5R01HL076206-04
|
|
Urokinase, Neutrophil Activation and Acute Lung Injury
|
ABRAHAM, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$323,329
|
|
Septicemia
|
NIAID
|
5R01AI059742-03
|
|
Regulation of Chemokine Receptor Expression in Sepsis
|
SHERRY, BARBARA
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$275,048
|
|
Septicemia
|
NIGMS
|
5K08GM069977-06
|
|
Erythrocyte Nitrosothiol Flux and Vasoregulation in Lung
|
DOCTOR, ALLAN
|
WASHINGTON UNIVERSITY
|
MO
|
$120,717
|
|
Septicemia
|
NIAID
|
5R01AI035875-16
|
|
FcR Deficient Mice Susceptibility to Pathogens
|
RAVETCH, JEFFREY
|
ROCKEFELLER UNIVERSITY
|
NY
|
$353,697
|
|
Septicemia
|
NICHD
|
5U10HD049983-04
|
|
Metoclopramide prevents PICU nosocomial infection
|
CARCILLO, JOSEPH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$411,301
|
|
Septicemia
|
NIGMS
|
1K08GM083207-01
|
|
Role of Cyclooxygenase-2-derived Prostanoids in Polymicrobial Sepsis
|
FREDENBURGH, LAURA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$130,950
|
|
Septicemia
|
NIGMS
|
1K08GM083212-01
|
|
ASDAMTS-13 and Inflammation
|
NGUYEN, TRUNG
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$115,589
|
|
Septicemia
|
NIGMS
|
1K23GM083211-01
|
|
Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in Sepsis
|
TRZECIAK, STEPHEN
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
NJ
|
$117,331
|
|
Septicemia
|
NIAID
|
5R01AI065981-02
|
|
Iron and pathogenesis in infections by Vibrio vulnificus
|
CROSA, JORGE
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$377,685
|
|
Septicemia
|
NIAAA
|
1R01AA016348-01A2
|
|
In Utero Alcohol and Alveolar Macrophage Maturation-A Risk For The Newborn
|
GAUTHIER, THERESA
|
EMORY UNIVERSITY
|
GA
|
$344,682
|
|
Septicemia
|
NIAID
|
1R01AI073342-01A1
|
|
Molecular Detection of Blood Stream Infections in Women with Gynecologic Cancer
|
JORDAN, JEANNE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$289,940
|
|
Septicemia
|
NIAID
|
5R01AI060818-04
|
|
Structure-function studies of endotoxin receptor CD14
|
JAIN, NITIN
|
UNIVERSITY OF TENNESSEE KNOXVILLE
|
TN
|
$269,748
|
|
Septicemia
|
NCI
|
5R01CA081140-11
|
|
Model for Gene Therapy in X-linked Agammaglobulinemia
|
RAWLINGS, DAVID
|
CHILDREN'S HOSPITAL AND REG MEDICAL CTR
|
WA
|
$297,611
|
|
Septicemia
|
NIDDK
|
5R01DK068097-03
|
|
Neutrophil-macrophage Interactions Govern Liver Immunity
|
GREGORY, STEPHEN
|
RHODE ISLAND HOSPITAL (PROVIDENCE, RI)
|
RI
|
$256,926
|
|
Septicemia
|
NIGMS
|
2R01GM066189-05A2
|
|
Adenosine in trauma and sepsis
|
HASKO, GYORGY
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$274,560
|
|
Septicemia
|
NIAID
|
5R01AI072577-02
|
|
Molecular Epidemiology, Virulence, and Genomic Characterization of Ureaplasmas
|
WAITES, KEN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$400,252
|
|
Septicemia
|
NIAID
|
5R01AI059010-04
|
|
Mouse model for sepsis
|
WARREN, H
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$382,369
|
|
Septicemia
|
NIAID
|
5R01AI057555-06
|
|
TpI2 Kinase in Macrophage Activation by Microbes
|
SUN, SHAO-CONG
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$322,304
|
|
Septicemia
|
NIAID
|
5R37AI018797-26
|
|
DIFFERENTIATIVE SIGNALS FOR MACROPHAGE ACTIVATION
|
VOGEL, STEFANIE
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$622,219
|
|
Septicemia
|
NHLBI
|
5R01HL081655-03
|
|
The Lung as a Source of Inflammation in Sepsis
|
MILLER, EDMUND
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$401,751
|
|
Septicemia
|
NIGMS
|
5K08GM074117-05
|
|
Cytochrome oxidase inhibition in septic heart
|
LEVY, RICHARD
|
NEW YORK MEDICAL COLLEGE
|
NY
|
$127,062
|
|
Septicemia
|
NCCAM
|
1R01AT003643-01A2
|
|
Vitamin C in Polymicrobial Sepsis
|
WILSON, JOHN
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$346,439
|
|
Septicemia
|
NIAID
|
2R01AI018188-27A1
|
|
Interactions of Endotoxin with Plasma and Cells
|
MUNFORD, ROBERT
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$447,864
|
|
Septicemia
|
NIAID
|
2R01AI071295-05A2
|
|
Roles for coagulation in immunity
|
SMILEY, STEPHEN
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$445,000
|
|
Septicemia
|
NIGMS
|
5R01GM064640-07
|
|
Heart Rate Characteristics Monitoring in Newborn Infant
|
MOORMAN, JOSEPH
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$318,115
|
|
Septicemia
|
NIAID
|
5R01AI068804-02
|
|
Host Susceptibility S. aureus
|
FOWLER, VANCE
|
DUKE UNIVERSITY
|
NC
|
$847,582
|
|
Septicemia
|
NIAID
|
1R01AI070955-01A2
|
|
Identification of vaccine antigens based on expression in blood
|
BEERNINK, PETER
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
CA
|
$400,000
|
|
Septicemia
|
NIGMS
|
4R37GM044118-17
|
|
Prevention of Apoptotic Cell Death in Sepsis by BCL-2
|
HOTCHKISS, RICHARD
|
WASHINGTON UNIVERSITY
|
MO
|
$462,016
|
|
Septicemia
|
NIGMS
|
4R37GM044100-19
|
|
Nitric Oxide and Hepatic Function in Sepsis and Trauma
|
BILLIAR, TIMOTHY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$303,000
|
|
Septicemia
|
NHLBI
|
5R01HL069511-07
|
|
Mediators and Mechanisms of Innate Immunity in the Lung
|
GERARD, CRAIG
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$410,248
|
|
Septicemia
|
NIAID
|
5R01AI068043-02
|
|
Molecular epidemiologic identification of pneumococcal tissue specific genes
|
PETTIGREW, MELINDA
|
YALE UNIVERSITY
|
CT
|
$547,609
|
|
Septicemia
|
NINR
|
1R01NR010015-01A2
|
|
PROTECTIVE EFFECTS OF DELAYED CORD CLAMPING IN VLBW INFANTS
|
MERCER, JUDITH
|
UNIVERSITY OF RHODE ISLAND
|
RI
|
$409,169
|
|
Septicemia
|
NIAID
|
1R03AI067569-01A2
|
|
Prophage-associated virulence factors in pathogenic Neisseria species
|
KARLS, ANNA
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$73,750
|
|
Septicemia
|
NIAID
|
5R01AI063382-03
|
|
Vaccine Strategies for Disseminated Candidiasis
|
EDWARDS, JOHN
|
LA BIOMED RES INST/ HARBOR UCLA MED CTR
|
CA
|
$331,593
|
|
Septicemia
|
NHLBI
|
5K23HL080077-04
|
|
Estrogen and the Pathophysiology and Outcomes of Sepsis
|
PIETROPAOLI, ANTHONY
|
UNIVERSITY OF ROCHESTER
|
NY
|
$150,721
|
|
Septicemia
|
NIAID
|
5R01AI054458-05
|
|
Cytokine-mediated T cell activation
|
SLIFKA, MARK
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$316,025
|
|
Septicemia
|
NIAID
|
5R01AI046645-08
|
|
Risk factors for drug resistant pneumococcal bacteremia
|
METLAY, JOSHUA
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$644,259
|
|
Septicemia
|
NHLBI
|
2R01HL064896-09A1
|
|
MICROSCOPIC IMAGING OF ALVEOLAR FUNCTION
|
BHATTACHARYA, JAHAR
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$402,500
|
|
Septicemia
|
NIGMS
|
5R01GM042686-16
|
|
Death Receptors in Sepsis
|
HARLAN, JOHN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$272,657
|
|
Septicemia
|
NIAID
|
1R21AI073818-01A1
|
|
MtaR-regulated virulence in Streptococcus agalactiae
|
SHELVER, DANIEL
|
LOUISIANA STATE UNIV HSC SHREVEPORT
|
LA
|
$216,542
|
|
Septicemia
|
NIGMS
|
5R01GM059930-08
|
|
IL-6 and hepatic dysfunction in sepsis
|
DEUTSCHMAN, CLIFFORD
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$306,578
|
|
Septicemia
|
NIAID
|
5K08AI062983-04
|
|
Mucosal colonization and dissemination of P. aeruginosa
|
KOH, ANDREW
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$128,120
|
|
Septicemia
|
NIGMS
|
5R01GM050870-15
|
|
MECHANISMS INVOLVED IN THE SEPTIC SHOCK SYNDROME
|
QURESHI, NILOFER
|
UNIVERSITY OF MISSOURI KANSAS CITY
|
MO
|
$305,521
|
|
Septicemia
|
NIGMS
|
5K08GM077432-03
|
|
The immunomodulatory effects of extracellular Hsp70
|
WHEELER, DEREK
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$120,950
|
|
Septicemia
|
NIGMS
|
5R01GM066202-06
|
|
Gut Epithelial Apopotosis in Shock and Sepsis
|
COOPERSMITH, CRAIG
|
WASHINGTON UNIVERSITY
|
MO
|
$319,200
|
|
Septicemia
|
NIAID
|
5R01AI028568-20
|
|
HIV 1 specific T cell clones
|
WALKER, BRUCE
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$366,256
|
|
Septicemia
|
NIAID
|
5R01AI070603-02
|
|
Roles and Mechanisms of gp96 in Chaperoning Innate Immunity
|
LI, ZIHAI
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$362,970
|
|
Septicemia
|
NIAID
|
5R01AI057366-04
|
|
C1 INHIBITOR-MEDIATED PROTECTION FROM ENDOTOXIN SHOCK
|
DAVIS, ALVIN
|
IMMUNE DISEASE INSTITUTE, INC.
|
MA
|
$439,502
|
|
Septicemia
|
NIDDK
|
1R43DK080529-01
|
|
Selective Cytopheresis Therapy in Systemic Inflammatory Response Syndrome
|
BUFFINGTON, DEBORAH
|
INNOVATIVE BIOTHERAPIES, INC.
|
MI
|
$251,405
|
|
Septicemia
|
NHLBI
|
5R01HL079368-03
|
|
MECHANISMS OF MICROVASCULAR THROMBOSIS IN ENDOTOXEMIA
|
RUMBAUT, ROLANDO
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$296,580
|
|
Septicemia
|
NIAID
|
5R01AI063433-03
|
|
Function of MVFR in Pseudomonas aeruginosa virulence
|
RAHME, LAURENCE
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$380,879
|
|
Septicemia
|
NHLBI
|
1R44HL091602-01
|
|
A Novel Therapy for Septic Shock
|
WU, RONGQIAN
|
THERASOURCE, LLC
|
NY
|
$429,458
|
|
Septicemia
|
NIAID
|
5K08AI065461-03
|
|
The effects of A2A adenosine receptor agonists in sepsis
|
MOORE, CHRISTOPHER
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$122,283
|
|
Septicemia
|
NHLBI
|
5R01HL048872-16
|
|
Regulation of Inducible Gene Expression in Monocytes
|
MACKMAN, NIGEL
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$365,000
|
|
Septicemia
|
NHLBI
|
1F32HL091644-01
|
|
Erythrocyte Transfusion in Acute Lung Injury During Sepsis
|
PATEL, NILAM
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$56,702
|
|
Septicemia
|
NIAID
|
5R41AI072912-02
|
|
TLR5 Antagonists for Infectious Disease Therapy
|
LORY, STEPHEN
|
MICROBIOTIX, INC
|
MA
|
$300,000
|
|
Septicemia
|
NHLBI
|
5R01HL057204-09
|
|
Mechanical Injury of the Alveolar Epithelium
|
MARGULIES, SUSAN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$417,426
|
|
Septicemia
|
NIGMS
|
5R01GM070727-03
|
|
Cholinergic regulation of endothelial cell activation
|
METZ, CHRISTINE
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$246,731
|
|
Septicemia
|
NIGMS
|
5K08GM070812-05
|
|
Matrix Metalloproteinases in Gastric Injury
|
ROBINSON, EMILY
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$119,205
|
|
Septicemia
|
NIGMS
|
5R01GM076685-03
|
|
Checkpoints of TNF Gene Regulation
|
GOLDFELD, ANNE
|
IMMUNE DISEASE INSTITUTE, INC.
|
MA
|
$340,229
|
|
Septicemia
|
NHLBI
|
5K23HL084097-03
|
|
Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis
|
JOURNEYCAKE, JANNA
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$108,000
|
|
Septicemia
|
NIAMS
|
5K08AR051563-04
|
|
Regulation of Protein Synthesis in Neonatal Sepsis
|
ORELLANA, RENAN
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$122,850
|
|
Septicemia
|
NIDDK
|
5R01DK067928-05
|
|
Redox-mediated NF-kappaB activation by LPS and IL-1
|
ENGELHARDT, JOHN
|
UNIVERSITY OF IOWA
|
IA
|
$274,118
|
|
Septicemia
|
NIAID
|
5K23AI062975-04
|
|
Risk Factors and Outcomes of Candidemia in Children
|
ZAOUTIS, THEOKLIS
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$133,272
|
|
Septicemia
|
NIA
|
5R01AG025908-04
|
|
Vulnerability to sepsis in old age
|
SAITO, HIROSHI
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$210,467
|
|
Septicemia
|
NIGMS
|
5R41GM079810-02
|
|
Lactoferrin for Immunomodulation of Systemic Inflammatory Response Syndrome
|
ACTOR, JEFFREY
|
PHARMAREVIEW CORPORATION
|
TX
|
$94,600
|
|
Septicemia
|
NIGMS
|
5R01GM079360-02
|
|
Impact of nitric oxide synthase on myocardial dysfunction of sepsis
|
ICHINOSE, FUMITO
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$315,400
|
|
Septicemia
|
NIGMS
|
5R01GM071398-04
|
|
Endothelial Toll-Like Receptor-4 Signaling in Sepsis
|
HARLAN, JOHN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$215,616
|
|
Septicemia
|
NIAID
|
5K23AI062279-05
|
|
Immune Correlates of Protection in Drug-Resistant HIV
|
EMU, BRINDA
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$121,770
|
|
Septicemia
|
NIAID
|
1R01AI074417-01A1
|
|
PD-1 blockade as a therapy for SIV/AIDS
|
AMARA, RAMA RAO
|
EMORY UNIVERSITY
|
GA
|
$716,507
|
|
Septicemia
|
NICHD
|
5R01HD048562-04
|
|
Impact of Neonatal Heart Rate Characteristics Monitoring
|
MOORMAN, JOSEPH
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$465,666
|
|
Septicemia
|
NIAID
|
5R37AI051178-07
|
|
Significance of Low Level Viremia in Patients on HAART
|
SILICIANO, ROBERT
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$241,326
|
|
Septicemia
|
NHLBI
|
5R44HL090636-03
|
|
Rapid Detection of Bacterial Contamination in Platelets
|
RIEDER, RONALD
|
BIOSENSE TECHNOLOGIES, INC.
|
MA
|
$384,144
|
|
Septicemia
|
NHLBI
|
5R01HL079104-03
|
|
3-OST-1 Regulation of Antithrombin Isoform Partitioning
|
SHWORAK, NICHOLAS
|
DARTMOUTH COLLEGE
|
NH
|
$502,007
|
|
Septicemia
|
NHLBI
|
5R01HL070891-05
|
|
C/EBP Beta Regulation of Lung Inflammation
|
STECENKO, ARLENE
|
EMORY UNIVERSITY
|
GA
|
$362,679
|
|
Septicemia
|
NIA
|
5R01AG028352-03
|
|
Regulation of Age-Related Inflammation in Septic Shock
|
WANG, PING
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$321,872
|
|
Septicemia
|
NICHD
|
5R01HD053719-02
|
|
Prevention of neonatal infection in the Indian community setting using probiotics
|
PANIGRAHI, PINAKI
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$447,019
|
|
Septicemia
|
NIAID
|
5R44AI052587-07
|
|
Inhibitors of Anthrax Lethal Factor Metalloproteinase
|
JOHNSON, ALAN
|
PANTHERA BIOPHARMA, LLC
|
HI
|
$882,133
|
|
Septicemia
|
NINDS
|
5K02NS053883-03
|
|
The Role of Infection in Childhood Stroke
|
FULLERTON, HEATHER
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$170,362
|
|
Septicemia
|
NIAID
|
5R01AI025011-16
|
|
Complement Anaphylatoxin Receptors in Inflammation
|
WETSEL, RICK
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$347,629
|
|
Septicemia
|
NIAID
|
5R01AI065029-03
|
|
Functional and Structural Studies of CD74 Activation
|
LOLIS, ELIAS
|
YALE UNIVERSITY
|
CT
|
$394,019
|
|
Septicemia
|
NIAID
|
5R01AI058106-05
|
|
Modulation of inflammation and sepsis by bacterial PAL
|
HELLMAN, JUDITH
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$23,872
|
|
Septicemia
|
NHLBI
|
5K08HL085525-03
|
|
Monocyte Pyrin Expression in Human Sepsis
|
HALL, MARK
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$132,300
|
|
Septicemia
|
NIAID
|
5R01AI030479-19
|
|
PHOP REGULON AND SALMONELLA VIRULENCE
|
MILLER, SAMUEL
|
UNIVERSITY OF WASHINGTON
|
WA
|
$362,328
|
|
Septicemia
|
NIAID
|
5R44AI065000-03
|
|
Bacterial-Induced Sepsis: A New Treatment Strategy
|
MCCOY, SHARON
|
TARGETED GENE DELIVERY, INC.
|
OR
|
$393,525
|
|
Septicemia
|
NIAID
|
1R01AI077706-01
|
|
Immune System Biological Networks:Case Study Improved Data Integration & Analysis
|
COWELL, LINDSAY
|
DUKE UNIVERSITY
|
NC
|
$377,680
|
|
Septicemia
|
NCRR
|
5K23RR020042-04
|
|
MENTORED PATIENT-ORIENTED RESEARCH CAREEER DEVELOPMENT AWARD
|
POUTSIAKA, DEBRA
|
TUFTS MEDICAL CENTER
|
MA
|
$150,390
|
|
Septicemia
|
NHLBI
|
5K23HL073832-05
|
|
rBPI-21 in Children Undergoing Cardiopulmonary Bypass
|
MOLITOR-KIRSCH, ERICA
|
CHILDREN'S MERCY HOSP (KANSAS CITY, MO)
|
MO
|
$108,000
|
|
Septicemia
|
NIGMS
|
1K08GM084143-01
|
|
Sepsis Induced Immune Cell Death and Multiple Organ Failure
|
MUENZER, JARED
|
WASHINGTON UNIVERSITY
|
MO
|
$107,433
|
|
Septicemia
|
NIDDK
|
5R01DK037908-18
|
|
Muscle Protein Turnover and Amino Acid Uptake in Sepsis
|
HASSELGREN, PER-OLOF
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$298,464
|
|
Septicemia
|
NIAID
|
5R01AI062446-03
|
|
HIV Vaccines on Latent Reservoirs in Young Adults on HAART
|
PERSAUD, DEBORAH
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$390,546
|
|
Septicemia
|
NIAID
|
1U01AI077764-01
|
|
Glanders Vaccine Developement
|
WOODS, DONALD
|
UNIVERSITY OF CALGARY
|
CANADA
|
$359,197
|
|
Septicemia
|
NIGMS
|
5K08GM071568-06
|
|
Viral Modulation of the Inflammatory Response
|
DOUGHTY, LESLEY
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$120,096
|
|
Septicemia
|
NIAID
|
5U01AI066581-04
|
|
Real-Time PCR Assays for Direct Detection of Sepsis and CAP Pathogens
|
KEIM, PAUL
|
TRANSLATIONAL GENOMICS RESEARCH INST
|
AZ
|
$607,974
|
|
Septicemia
|
NIAID
|
5R01AI068956-02
|
|
The Role of MKP-1 in innate immune responses to LPS
|
LIU, YUSEN
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$273,699
|
|
Septicemia
|
NHLBI
|
1R15HL092504-01
|
|
Statins as inhibitors of bacterial host cell invasion
|
MCDOWELL, SUSAN
|
BALL STATE UNIVERSITY
|
IN
|
$216,750
|
|
Septicemia
|
NIAID
|
1U01AI077947-01
|
|
Preclinical development of DS-96, a novel alkylpolyamine endotoxin squestrant
|
DAVID, SUNIL
|
UNIVERSITY OF KANSAS LAWRENCE
|
KS
|
$352,724
|
|
Septicemia
|
NIAID
|
5R01AI075159-02
|
|
Regulation of TLR Signaling and Innate Immunity by RP105
|
KARP, CHRISTOPHER
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$367,875
|
|
Septicemia
|
NIAID
|
1U01AI078067-01
|
|
Antidotes to Anthrax Lethal Factor Intoxication
|
JOHNSON, ALAN
|
PANTHERA BIOPHARMA, LLC
|
HI
|
$830,000
|
|
Septicemia
|
NIGMS
|
5T32GM008593-13
|
|
Training in Trauma, Inflammation, Sepsis and Critical Care
|
NWARIAKU, FIEMU
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$188,065
|
|
Septicemia
|
NHLBI
|
5K08HL085282-03
|
|
Endotoxin Neutralization by HDL-Mimetic Peptide
|
GUPTA, HIMANSHU
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$126,549
|
|
Septicemia
|
NHLBI
|
5R01HL076528-04
|
|
Lung Injury Protection by Coagulation Blockade
|
PIANTADOSI, CLAUDE
|
DUKE UNIVERSITY
|
NC
|
$369,790
|
|
Septicemia
|
NIGMS
|
5R01GM053249-12
|
|
Nitric Oxide Synthase 2 in Endotoxemia and Sepsis
|
PERRELLA, MARK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$256,721
|
|
Septicemia
|
NHLBI
|
5R01HL085357-03
|
|
Hemostatic Factors as Determinants of Bacterial Virulence and Host Defense
|
DEGEN, JAY
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$364,125
|
|
Septicemia
|
NINR
|
5R01NR009078-04
|
|
Technological Home Care: Improving Caregiving
|
SMITH, CAROL
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$476,896
|
|
Septicemia
|
NIGMS
|
5K08GM076344-03
|
|
PARP-1 is a Negative Modulator of the Heart Shock Response
|
ANEJA, RAJESH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$122,931
|
|
Septicemia
|
NIAAA
|
5R01AA011660-08
|
|
GM-CSF responsiveness in alcohol-mediated lung injury
|
GUIDOT, DAVID
|
EMORY UNIVERSITY
|
GA
|
$290,143
|
|
Septicemia
|
NIGMS
|
5K08GM073141-04
|
|
Aging, Increased IL-6, Burn, and Myocardial Depression
|
TAO, WEIKE
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$118,800
|
|
Septicemia
|
NIAID
|
5R01AI030165-17
|
|
POST-TRANSCRIPTIONAL REGULATION OF INFLAMMATORY MEDIATORS
|
DING, AIHAO
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$412,020
|
|
Septicemia
|
NIDDK
|
5R21DK074889-02
|
|
H.Pylori Infection in Hispanic Children: Immune response pathway SNP pattterns
|
BROWN, ERIC
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$188,171
|
|
Septicemia
|
NCI
|
2R01CA021923-30A2
|
|
OLIGOSACCHARIDE STRUCTURE & FUNCTION IN RECOGNITION
|
BAENZIGER, JACQUES
|
WASHINGTON UNIVERSITY
|
MO
|
$635,637
|
|
Septicemia
|
NIAID
|
1R01AI070289-01A2
|
|
Genetic Basis of Virulence of Community MRSA Clone USA300
|
CHAMBERS, HENRY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$382,675
|
|
Septicemia
|
NIAID
|
1R01AI073872-01A1
|
|
ClC-3 ion transport modulates NADPH oxidase-dependent PMN priming by endotoxin
|
MORELAND, JESSICA
|
UNIVERSITY OF IOWA
|
IA
|
$375,000
|
|
Septicemia
|
NCRR
|
5K23RR019544-03
|
|
TSP-1: A mediator of sepsis-induced lung injury
|
ALI, NAEEM
|
OHIO STATE UNIVERSITY
|
OH
|
$131,936
|
|
Septicemia
|
NHLBI
|
5R01HL081474-05
|
|
Proteoglycans in Sepsis
|
PARK, PYONG
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$320,012
|
|
Septicemia
|
NIAID
|
2R01AI052455-06A1
|
|
Group B. Streptococci and Toll-like Receptors
|
GOLENBOCK, DOUGLAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$381,861
|
|
Septicemia
|
NIAID
|
2R01AI041637-11A1
|
|
Cellular Activation Mechanisms in Septic Shock
|
HAN, JIAHUAI
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$473,750
|
|
Septicemia
|
NCRR
|
5K23RR020069-04
|
|
MENTORED PATIENT-ORIENTED RESEARCH CAREEER DEVELOPMENT AWARD
|
FREISHTAT, ROBERT
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$124,686
|
|
Septicemia
|
NIGMS
|
2R37GM054060-13
|
|
Phagocyte Receptors for Lipid A
|
GOLENBOCK, DOUGLAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$470,766
|
|
Septicemia
|
NICHD
|
1R01HD056123-01A1
|
|
The Role of Decidual Innate Immunity in the Pathogenesis of Preeclampsia
|
HUANG, SE-TE
|
YALE UNIVERSITY
|
CT
|
$344,754
|
|
Septicemia
|
NIDDK
|
2K24DK002886-06
|
|
Polyomavirus and Mentoring in Renal Transplantation
|
BRENNAN, DANIEL
|
WASHINGTON UNIVERSITY
|
MO
|
$168,234
|
|
Septicemia
|
NIDDK
|
1R21DK078717-01A1
|
|
Predictors of Hospital-Acquired Urinary Tract-Related Bloodstream Infection
|
SAINT, SANJAY
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$190,000
|
|
Septicemia
|
NIDDK
|
5K08DK073519-03
|
|
Kupffer Cell Survival and Function During the Evolution of Pseudomonas Sepsis
|
ASHARE, ALIX
|
UNIVERSITY OF IOWA
|
IA
|
$126,630
|
|
Septicemia
|
NIAID
|
5R01AI059502-05
|
|
Virulence regulation in group B Streptococcus
|
WESSELS, MICHAEL
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$350,095
|
|
Septicemia
|
NIGMS
|
5R01GM079239-02
|
|
Critical Role of Nrf2 in Innate Immune Response and Survival During Sepsis
|
BISWAL, SHYAM
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$318,262
|
|
Septicemia
|
NHLBI
|
5R01HL062221-08
|
|
Neutrophil Activation in Acute Lung Injury
|
ABRAHAM, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$353,201
|
|
Septicemia
|
NHLBI
|
5R01HL083019-02
|
|
Pathogenesis of Liver-Dependent Acute Lung Injury
|
BRIGHAM, KENNETH
|
EMORY UNIVERSITY
|
GA
|
$382,500
|
|
Septicemia
|
NIGMS
|
5K23GM071399-04
|
|
Protocol Driven Hemodynamic Support in Septic Shock
|
SEVRANSKY, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$134,730
|
|
Septicemia
|
NIGMS
|
5R01GM063041-08
|
|
Targeted IL-10 Gene Therapy in Sepsis Syndromes
|
MOLDAWER, LYLE
|
UNIVERSITY OF FLORIDA
|
FL
|
$263,850
|
|
Septicemia
|
NIGMS
|
1R01GM081923-01A1
|
|
Myeloid Suppressor Cells in Sepsis and Trauma
|
MOLDAWER, LYLE
|
UNIVERSITY OF FLORIDA
|
FL
|
$263,700
|
|
Septicemia
|
NICHD
|
5R01GM080180-03
|
|
Sepsis and Critical Illness in Babies > 34 Weeks Gestation
|
ESCOBAR, GABRIEL
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
CA
|
$141,426
|
|
Septicemia
|
NIGMS
|
5R01GM080180-03
|
|
Sepsis and Critical Illness in Babies > 34 Weeks Gestation
|
ESCOBAR, GABRIEL
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
CA
|
$282,853
|
|
Septicemia
|
NHLBI
|
1R01HL085833-01A2
|
|
Targeted Suppression of Cytokine Signaling in the Acute Phase Response
|
HAWIGER, JACK
|
VANDERBILT UNIVERSITY
|
TN
|
$383,750
|
|
Septicemia
|
NIAID
|
5R43AI074120-02
|
|
Novel Multiplex Assay for Sepsis Biomarkers
|
WRIGHT, SUSAN
|
PANORAMA RESEARCH, INC.
|
CA
|
$261,520
|
|
Septicemia
|
NIGMS
|
5R01GM044764-17
|
|
Regulation of Macrophage Function in Surgical Sepsis
|
WEST, MICHAEL
|
NORTHWESTERN UNIVERSITY
|
IL
|
$295,692
|
|
Septicemia
|
NIAID
|
2R01AI023859-21A2
|
|
Role of CD14 and other innate immune receptors in severe sepsis
|
GOYERT, SANNA
|
CITY COLLEGE OF NEW YORK
|
NY
|
$385,000
|
|
Septicemia
|
NIMH
|
5K23MH071181-05
|
|
HIV/HCV: Neuropsychiatric and Neurophysiologic Features
|
RYAN, ELIZABETH
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$155,044
|
|
Septicemia
|
NHLBI
|
5K23HL085526-02
|
|
Targeted Genomic Analysis of Coagulation Pathways in Acute Lung Injury
|
SAPRU, ANIL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$151,200
|
|
Septicemia
|
NIA
|
5R21AG024208-02
|
|
Aging and Immune Response in Sepsis
|
LAGOO-DEENADAYALAN, SANDHYA
|
DUKE UNIVERSITY
|
NC
|
$188,042
|
|
Septicemia
|
NIGMS
|
5R01GM039277-18
|
|
REGULATION OF PROTEIN TURNOVER IN SEPSIS
|
VARY, THOMAS
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$249,378
|
|
Septicemia
|
NIGMS
|
5R01GM055639-11
|
|
Mechanisms of Growth Hormone Resistance in Sepsis
|
COONEY, ROBERT
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$269,894
|
|
Septicemia
|
NIGMS
|
5K23GM076652-03
|
|
Randomized Clinical Trial of a Less-Invasive Resuscitation Protocol for Sepsis
|
JONES, ALAN
|
CAROLINAS MEDICAL CENTER
|
NC
|
$119,610
|
|
Septicemia
|
NIAID
|
5R21AI070929-02
|
|
Creation of a conditional IL-6 knockout mouse
|
DEUTSCHMAN, CLIFFORD
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$193,134
|
|
Septicemia
|
NIAID
|
5U01AI066584-04
|
|
Diagnostics for Sepsis and Community-Acquired Pneumonia
|
WEISBURG, WILLIAM
|
NANOGEN, INC.
|
CA
|
$472,430
|
|
Septicemia
|
NIAID
|
1R43AI078567-01
|
|
Detection of Antibiotic Resistance Genes in Bacterial Agents of Hospital-Acquired
|
LEVIN, ANDREW
|
IMMUNETICS, INC.
|
MA
|
$299,999
|
|
Septicemia
|
NIAID
|
1R43AI069570-01A1
|
|
Single Step Surface Modification of NonFluorinated Polymers for Infection Control
|
DENVIR, ADRIAN
|
LYNNTECH, INC.
|
TX
|
$101,964
|
|
Septicemia
|
NHLBI
|
1R44HL091573-01A1
|
|
Development of B-Lock, an antibiofilm catheter lock product
|
APPELT, KRZYSZTOF
|
GREAT LAKES PHARMACEUTICALS, INC.
|
OH
|
$100,000
|
|
Septicemia
|
NCCAM
|
1R43AT004549-01A1
|
|
Botanical Treatment of DIC in Sepsis
|
PALMER, MARY
|
TOXEM, LLC
|
VA
|
$120,000
|
|
Septicemia
|
NIEHS
|
5F30ES015950-02
|
|
Redox Mediated Signaling in the Toll-like Receptor Family
|
OAKLEY, FREDRICK
|
UNIVERSITY OF IOWA
|
IA
|
$26,531
|
|
Septicemia
|
NIAID
|
5U01AI075351-02
|
|
Dendrimer aminosaccharide drug to modulate inflammatory responses in shigellosis
|
SHAUNAK, SUNIL
|
U OF L IMPERIAL COL OF SCI/TECHNLGY/MED
|
UK
|
$333,442
|
|
Septicemia
|
NIGMS
|
5T32GM008516-15
|
|
Training in Trauma and Sepsis Research
|
BILLIAR, TIMOTHY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$260,104
|
|
Septicemia
|
NIGMS
|
1F32GM082008-01A1
|
|
The Role of Epidermal Growth Factor in Sepsis
|
CLARK, JESSICA
|
WASHINGTON UNIVERSITY
|
MO
|
$49,646
|
|
Septicemia
|
NHLBI
|
5K08HL086668-02
|
|
Efficacy of Activated Protein C in Ventilator Associated Lung Injury
|
FINIGAN, JAMES
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$134,730
|
|
Septicemia
|
NIAID
|
5R01AI068814-02
|
|
JAK/STAT signaling in Drosophila acute phase response
|
AGAISSE, HERVE
|
YALE UNIVERSITY
|
CT
|
$324,711
|
|
Septicemia
|
NIGMS
|
5R01GM063075-05
|
|
Regulation of HMGB1 Release in Endotoxemia
|
WANG, HAICHAO
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$248,581
|
|
Septicemia
|
NIEHS
|
5U01ES016014-02
|
|
Biomarker signatures of biological, chemical, or psychological stress
|
LAWRENCE, DAVID
|
WADSWORTH CENTER
|
NY
|
$581,287
|
|
Septicemia
|
NIDDK
|
5R01DK069929-04
|
|
Gastric Injury In Trauma and Surgical Sepsis
|
SOYBEL, DAVID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$238,061
|
|
Septicemia
|
NIAID
|
5U01AI066590-04
|
|
Microfluidic PCR Platform to Detect Microbial DNA
|
MITCHELL, THOMAS
|
DUKE UNIVERSITY
|
NC
|
$617,154
|
|
Septicemia
|
NIGMS
|
5K08GM078610-03
|
|
Gram-Negative Pneumonia and Lipopolysaccharide Binding Protein
|
HEMMILA, MARK
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$128,520
|
|
Septicemia
|
NHLBI
|
5R01HL060788-11
|
|
Role of Heme Oxygenase-1 in Sepsis
|
PERRELLA, MARK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$407,500
|
|
Septicemia
|
NIAID
|
5U01AI066576-04
|
|
Point of Care Nucleic Acid Diagnostic Device for Quantifying Bacteremia
|
NOLLING, JORK
|
IQUUM, INC.
|
MA
|
$368,621
|
|
Septicemia
|
NIGMS
|
5K08GM071646-05
|
|
Genetics of Innate Immune Response after Burn Trauma
|
RIVERA, FERNANDO
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$119,610
|
|
Septicemia
|
NHLBI
|
5R01HL080926-04
|
|
Systems Engineering of Pheresis Intervention for Sepsis
|
KELLUM, JOHN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$1,470,774
|
|
Septicemia
|
NIGMS
|
5R01GM072808-04
|
|
Mechanisms of Intestinal Apoptosis in Sepsis and Shock
|
COOPERSMITH, CRAIG
|
WASHINGTON UNIVERSITY
|
MO
|
$249,695
|
|
Septicemia
|
NIGMS
|
5R01GM077279-02
|
|
The Functional of TREM-1 in Sepsis
|
COLONNA, MARCO
|
WASHINGTON UNIVERSITY
|
MO
|
$288,800
|
|
Septicemia
|
NIDDK
|
5R01DK072372-04
|
|
Hepatic CYP enzymes and host-pathogen interactions
|
MORGAN, EDWARD
|
EMORY UNIVERSITY
|
GA
|
$380,026
|
|
Septicemia
|
NIGMS
|
5R01GM064619-05
|
|
Genomic analysis of pediatric SIRS and septic shock
|
WONG, HECTOR
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$328,584
|
|
Septicemia
|
NIGMS
|
5R01GM072760-04
|
|
Role of HIF-1a in T Cells During Sepsis
|
CALDWELL, CHARLES
|
UNIVERSITY OF CINCINNATI
|
OH
|
$227,052
|
|
Septicemia
|
NIGMS
|
5R01GM062508-08
|
|
HMG in Post Operative and Traumatic Stress
|
TRACEY, KEVIN
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$289,433
|
|
Septicemia
|
NIGMS
|
5K08GM074678-04
|
|
Immunomodulation of Sepsis in Biliary Obstruction
|
MINTER, REBECCA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$128,520
|
|
Septicemia
|
NIGMS
|
5R01GM061656-07
|
|
Protective effects of anti-C5a in sepsis
|
WARD, PETER
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$301,944
|
|
Septicemia
|
NIGMS
|
5R37GM067759-06
|
|
Mutagenetic analysis of LPS responses
|
BEUTLER, BRUCE
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$896,021
|
|
Septicemia
|
NIGMS
|
5R01GM073825-03
|
|
Modifier genes of sepsis
|
DE MAIO, ANTONIO
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$289,433
|
|
Septicemia
|
NIGMS
|
5R01GM078054-02
|
|
TRAUMA & SEPSIS INDUCED CHANGES IN IMMUNE CELL MEMBRANE RECEPTOR TRAFFICKING
|
CUSCHIERI, JOSEPH
|
UNIVERSITY OF WASHINGTON
|
WA
|
$249,042
|
|
Septicemia
|
NIGMS
|
5R01GM061761-08
|
|
Elucidating structure-function relationships of lipid A: A synthetic approach
|
BOONS, GEERT-JAN
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$386,996
|
|
Septicemia
|
NIAAA
|
5R01AA012197-07
|
|
Chronic ethanol: mitochondrial dysfunction and apoptosis
|
BROWN, LOU ANN
|
EMORY UNIVERSITY
|
GA
|
$334,267
|
|
Septicemia
|
NIGMS
|
5R01GM078238-03
|
|
TLR4 signaling in the pathogenesis of surgical necrotizing enterocolitis
|
HACKAM, DAVID
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
PA
|
$268,787
|
|
Septicemia
|
NHLBI
|
5R01HL086667-02
|
|
Early Insulin Therapy and Development of ARDS
|
GONG, MICHELLE
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$454,040
|
|
Septicemia
|
NIGMS
|
5R01GM057468-11
|
|
Sepsis and Mediators: the Role of MFG-E8
|
WANG, PING
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$339,617
|
|
Septicemia
|
NIAID
|
5U01AI066569-04
|
|
Plasma Protein Biomarker-Based Diagnostics Of Outcome In Sepsis and CAP
|
KINGSMORE, STEPHEN
|
NATIONAL CENTER FOR GENOME RESOURCES
|
NM
|
$491,218
|
|
Septicemia
|
NIAID
|
5U01AI075490-02
|
|
Integrated Dual-Use Systems for Bio-Defense & Sepsis Diagnosis
|
ALLAND, DAVID
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$434,892
|
|
Septicemia
|
NIAID
|
5U01AI075391-02
|
|
Development of an antimicrobial peptide therapeutic for Pseudomonas infections
|
PEREIRA, H.
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
OK
|
$592,713
|
|
Septicemia
|
NIAID
|
7U01AI075386-02
|
|
SHIGA-TOXINS: PRE-CLINICAL ANIMAL MODEL DEVELOPMENT AND THERAPEUTIC TESTING
|
KUROSAWA, SHINICHIRO
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$754,666
|
|
Septicemia
|
NINR
|
5R01NR008545-05
|
|
C/EBP, atrogin-1, and muscle wasting
|
HASSELGREN, PER-OLOF
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$347,883
|
|
Septicemia
|
NIAID
|
5U01AI066561-05
|
|
Rapid and Expandable Nucleic Acid Platform to Detect Bloodstream Infections
|
PERLIN, DAVID
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$757,554
|
|
Septicemia
|
NIGMS
|
5K08GM081459-02
|
|
Bacterial Pneumonia and Neutrophil Recruitment During Acute Renal Failure
|
SINGBARTL, KAI
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$120,795
|
|
Septicemia
|
NIGMS
|
5R01GM057226-09
|
|
Macrophage Inactivation in Sepsis after Shock or Trauma
|
TRACEY, KEVIN
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$372,750
|
|
Septicemia
|
NIGMS
|
5R01GM053522-11
|
|
Amelioration of Sepsis by Macrophage Activation
|
WILLIAMS, DAVID
|
EAST TENNESSEE STATE UNIVERSITY
|
TN
|
$287,077
|
|
Septicemia
|
NHLBI
|
1R01HL091757-01A1
|
|
Endothelial Cell Signaling and Microcirculatory Flow in Severe Sepsis
|
SHAPIRO, NATHAN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$433,329
|
|
Septicemia
|
NIGMS
|
5R01GM073883-03
|
|
Genetic and Functional Analysis of Drosophila Mmp 1
|
PAGE-MCCAW, ANDREA
|
RENSSELAER POLYTECHNIC INSTITUTE
|
NY
|
$268,636
|
|
Septicemia
|
NIGMS
|
5R01GM055194-12
|
|
Cellular Mechanisms of Sepsis and Organ Failure
|
HOTCHKISS, RICHARD
|
WASHINGTON UNIVERSITY
|
MO
|
$326,412
|
|
Septicemia
|
NIAID
|
5R21AI072459-03
|
|
Role of phase-variable DNA methylase in virulence of Haemophilus influenzae
|
SMITH, ARNOLD
|
CHILDREN'S HOSPITAL AND REG MEDICAL CTR
|
WA
|
$281,057
|
|
Septicemia
|
NHLBI
|
1R33HL089076-01A1
|
|
Mathematical Modeling of Inflammation in ARDS
|
NIEMAN, GARY
|
UPSTATE MEDICAL UNIVERSITY
|
NY
|
$472,278
|
|
Septicemia
|
NIGMS
|
5R01GM059960-09
|
|
Cellular Injury and Adaptation
|
COBB, J
|
WASHINGTON UNIVERSITY
|
MO
|
$311,905
|
|
Septicemia
|
NIAAA
|
5R21AA016571-02
|
|
Alcohol disrupts TLR4 signaling in lipid rafts
|
DOLGANIUC, ANGELA
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$192,969
|
|
Septicemia
|
NICHD
|
5K08HD051626-02
|
|
Contribution of the LDL receptor-related protein (LRP) to inflammation and sepsis
|
WILLIAMS, ERIC
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$129,060
|
|
Septicemia
|
NHLBI
|
1R33HL089082-01A1
|
|
Mathematical Modeling of Inflammation in ARDS
|
VODOVOTZ, YORAM
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$458,566
|
|
Septicemia
|
NINR
|
5R01NR010828-02
|
|
Impact of statins and ACE inhibitors on outcomes for pneumonia and sepsis
|
MORTENSEN, ERIC
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$311,563
|
|
Septicemia
|
NIGMS
|
1R01GM085112-01
|
|
Transcriptional regulation of Toll-like receptor signaling
|
CHEN, YOUHAI
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$315,000
|
|
Septicemia
|
NIGMS
|
1R01GM085231-01
|
|
Role of SR-BI in LPS detoxification
|
LI, XIANG-AN
|
UNIVERSITY OF KENTUCKY
|
KY
|
$230,738
|
|
Septicemia
|
NHLBI
|
1R01HL093234-01
|
|
Angiopoietin Mechanisms in Sepsis
|
PARIKH, SAMIR
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$425,000
|
|
Septicemia
|
NIGMS
|
1R01GM085063-01
|
|
Interferon-mediated reprogramming of Toll-like receptor signaling
|
DOUGHTY, LESLEY
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$285,000
|
|
Septicemia
|
NIAID
|
1R21AI079173-01
|
|
Pathogenesis of S. Typhimurium bacteremia
|
BAUMLER, ANDREAS
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$228,000
|
|
Septicemia
|
NHLBI
|
1R01HL093388-01
|
|
Mechanism of Activated Protein C Action in Sepsis Therapy
|
WEILER, HARTMUT
|
BLOODCENTER OF WISCONSIN, INC.
|
WI
|
$410,006
|
|
Septicemia
|
NHLBI
|
1K08HL093359-01
|
|
The Role of HMGB1 in Acute Lung Injury-Induced Endothelial Cell Permeability
|
WOLFSON, RACHEL
|
UNIVERSITY OF CHICAGO
|
IL
|
$124,443
|
|
Septicemia
|
NIAID
|
1R03AI079530-01
|
|
Adrenergic Control of Stem Cell Lineage Commitment in Sepsis
|
MUTHUMALAIAPPAN, KUZHALI
|
LOYOLA UNIVERSITY CHICAGO
|
IL
|
$74,250
|
|
Septicemia
|
NIGMS
|
2R01GM038032-22
|
|
Cytokine Regulation of Muscle Protein Synthesis During Infection
|
LANG, CHARLES
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$330,879
|
|
Septicemia
|
NIDDK
|
1R01DK075991-01A2
|
|
Mechanistic targets for intervention in sepsis-induced renal injury
|
MAYEUX, PHILIP
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
AR
|
$305,997
|
|
Septicemia
|
NIGMS
|
1R01GM082952-01A1
|
|
HDL Modulation of monocyte function in endotoxemia
|
DATTA, GEETA
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$267,634
|
|
Septicemia
|
NHLBI
|
2R01HL077753-05
|
|
TF Signaling in Systemic Inflammation
|
RUF, WOLFRAM
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$473,750
|
|
Septicemia
|
NIGMS
|
2R01GM049825-13A2
|
|
Genetic analysis of pleiotropic drug resistance
|
MOYE-ROWLEY, W
|
UNIVERSITY OF IOWA
|
IA
|
$324,820
|
|
Septicemia
|
NIGMS
|
2R01GM059281-11
|
|
Neutrophil Priming in Trauma and Sepsis
|
YAFFE, MICHAEL
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$361,200
|
|
Septicemia
|
NIGMS
|
2R01GM027673-27
|
|
Role of Eicosanoids in Shock
|
COOK, JAMES
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$348,275
|
|
Septicemia
|
NIGMS
|
2R01GM067202-05A1
|
|
PPARgamma and PPARgamma agonists in septic shock
|
ZINGARELLI, BASILIA
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$348,080
|
|
Septicemia
|
NIGMS
|
2R01GM040586-20
|
|
Cytokine Regulation in Sepsis/Inflammation
|
MOLDAWER, LYLE
|
UNIVERSITY OF FLORIDA
|
FL
|
$314,975
|
|
Septicemia
|
NIGMS
|
1R01GM084125-01A1
|
|
Cholinergic regulation of NF-kB in sepsis
|
ULLOA, LUIS
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$287,675
|
|
Septicemia
|
NIGMS
|
2R44GM073249-02A1
|
|
Treatment of Surgical Sepsis with AM/AMBP-1
|
WU, RONGQIAN
|
THERASOURCE, LLC
|
NY
|
$421,371
|
|
Septicemia
|
NIAID
|
1R43AI080001-01
|
|
Immunomodulation of Sophorolipids in Sepsis
|
NOWAKOWSKI, MAJA
|
BIOMEDICA MANAGEMENT CORPORATION
|
NY
|
$99,999
|
|
Septicemia
|
NIDDK
|
2R44DK074289-03
|
|
Cell Therapy for Septic Shock
|
BUFFINGTON, DEBORAH
|
INNOVATIVE BIOTHERAPIES, INC.
|
MI
|
$600,116
|
|
Septicemia
|
NIDDK
|
1R43DK082050-01
|
|
Enhanced Propagation of Adult Human Renal Epithelial Cells
|
WESTOVER, ANGELA
|
INNOVATIVE BIOTHERAPIES, INC.
|
MI
|
$137,388
|
|
Septicemia
|
NIAID
|
1R43AI078537-01A1
|
|
Antagonism of Alpha2A-Adrenoceptor: A Novel Anti-Sepsis Therapy
|
QIANG, XIAOLING
|
THERASOURCE, LLC
|
NY
|
$197,522
|
|
Septicemia
|
NICHD
|
1R44HD057744-01A1
|
|
Lactoferrin Enhances Growth and Reduces Nosocomial Infection in Preterm Infants
|
PETRAK, KAREL
|
AGENNIX, INC.
|
TX
|
$557,320
|
|
Septicemia
|
NIDDK
|
3R01DK072372-03S1
|
|
Hepatic CYP enzymes and host-pathogen interactions
|
MORGAN, EDWARD
|
EMORY UNIVERSITY
|
GA
|
$53,812
|
|
Septicemia
|
NHLBI
|
1F32HL090200-01A1
|
|
Modest supplemental oxygen worsens lung injury in a murine model of sepsis
|
AGGARWAL, NEIL
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$54,842
|
|
Septicemia
|
NIAID
|
1F32AI074271-01A2
|
|
Subcellular Protein Localization in Pseudomonas aeruginosa Virulence
|
COWLES, KIMBERLY
|
PRINCETON UNIVERSITY
|
NJ
|
$46,826
|
|
Septicemia
|
NIGMS
|
1F32GM086003-01
|
|
Hydrocortisone replacement therapy in septic neonatal foals
|
HART, KELSEY
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$57,398
|
|
